CStone Pharmaceuticals (HK:2616)
:2616
Comparison Results
CStone Pharmaceuticals
HK$5.34
HK$14.64B
-15.44
314.40%
2 Buy
0 Hold
0 Sell
Moderate Buy
Alphamab Oncology
HK$10.78
HK$9.15B
-76.25
69.23%
1 Buy
0 Hold
0 Sell
Moderate Buy
HBM Holdings Ltd.
HK$12.08
HK$12.61B
5.89
93.57%
1 Buy
0 Hold
0 Sell
Moderate Buy
Jiangsu Recbio Technology Co., Ltd. Class H
HK$4.18
HK$2.35B
-3.21
-27.75%
―
Abbisko Cayman Limited
HK$13.02
HK$9.01B
135.64
87.41%
3 Buy
0 Hold
0 Sell
Strong Buy
Shandong Boan Biotechnology Company., Limited. Class H
HK$7.07
HK$4.45B
552.34
-13.68%
―
Performance Comparison
HK:2616
CStone Pharmaceuticals
9.90
7.23
270.79%
HK:9966
Alphamab Oncology
10.78
4.13
62.11%
HK:2142
HBM Holdings Ltd.
13.84
6.07
78.12%
HK:2179
Jiangsu Recbio Technology Co., Ltd. Class H
5.00
-1.92
-27.75%
HK:2256
Abbisko Cayman Limited
12.80
5.60
77.78%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
7.07
-1.21
-14.61%